Ring chromosome 4 syndrome

Ring chromosome 4 syndrome (also known as r(4) syndrome or ring 4) is a rare chromosomal disorder in which the two ends of chromosome 4 break and rejoin to form a circular or ring-shaped structure. This process typically results in the loss of genetic material from one or both ends of the chromosome, leading to a variable clinical presentation depending on the extent of the deleted segments. The condition is usually not inherited but arises as a de novo event during early embryonic development or in the formation of reproductive cells. The syndrome primarily affects growth, neurodevelopment, and craniofacial structures. Key clinical features include significant prenatal and postnatal growth retardation, intellectual disability of variable severity, microcephaly, and distinctive facial features such as a broad or flat nasal bridge, micrognathia (small jaw), low-set ears, epicanthal folds, and a short nose. Skeletal anomalies, including clinodactyly and delayed bone age, may also be present. Some individuals may have congenital heart defects, genitourinary anomalies, and seizures. The phenotypic severity is highly variable and correlates with the amount of chromosomal material lost during ring formation and the degree of ring instability, which can lead to mosaicism. There is no cure or specific targeted therapy for ring chromosome 4 syndrome. Management is supportive and multidisciplinary, focusing on addressing individual symptoms. This may include early intervention programs, speech and physical therapy, special education services, cardiac evaluation and management if heart defects are present, and monitoring of growth and development. Genetic counseling is recommended for affected families to discuss recurrence risk and prognosis.

Common questions about Ring chromosome 4 syndrome